Generational Equity Advises Advanced Service Solutions in Sale to BHMS Investments

DALLAS, Jan. 18, 2018 /PRNewswire/ — Generational Equity, a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the acquisition of its client, Advanced Service Solutions Inc., by BHMS Investments. The transaction closed January 2, 2018.

Generational Equity Says Tax Reform Ensures Positive Outlook for Middle Market M&A

DALLAS, Jan. 10, 2018 /PRNewswire/ — Experts are predicting an acceleration of merger and acquisition activity in 2018 thanks to the passage and implementation of the major tax reform legislation signed last year by President Trump.

2017 Tax Reform Legislation and M&A Impact

DALLAS, Dec. 21, 2017 /PRNewswire/ — According to professionals with Generational Equity, an industry-leading M&A firm for middle market businesses, the tax reform bill recently passed by the U.S. Congress is one of many factors that indicate 2018 will be an ideal time to explore selling a business.

Generational Equity: 2018 Will Be a Great Time to Sell a Business

DALLAS, Dec. 14, 2017 /PRNewswire/ — A record high stock market, continued low interest rates and trillions of dollars in available capital will make 2018 an ideal time to sell a business, according to the professionals with Generational Equity, an industry-leading M&A firm for mid-market businesses.

Generational Equity Advises Self’s Inc. in Sale to E.J. Welch Company

DALLAS, Dec. 13, 2017 /PRNewswire/ — Generational Equity, a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the acquisition of its client, Self’s Inc., by E.J. Welch Company Inc. The transaction closed November 17, 2017.

Generational Capital Markets Advises Endeavor Clinical Trials in its Sale to Evolution Research Group

DALLAS, Dec. 13, 2017 /PRNewswire/ — Generational Capital Markets, Inc., Member FINRA/SIPC and a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the sale of its client, Endeavor Clinical Trials P.A. (ECT), to Evolution Research Group, LLC (ERG). The acquisition closed July 31, 2017.